Delivery Order SPE2DE24DA011-SPE2D625F9D4U
- Not listed
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $20,083.00 by the Defense Logistics Agency's Medical Supply Chain on July 15, 2025. This fixed-price delivery order with economic price adjustment provisions is scheduled for completion by July 18, 2025, and represents a task order issued under Arthrex's larger Indefinite Delivery Contract (IDC) SPE2DE24D0020 with the Defense Logistics Agency, valued at...
- Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies headquartered in Naples, Florida, was awarded a fixed-price delivery order valued at $1,073.17 by the Defense Logistics Agency's Medical Supply Chain on August 21, 2025. The delivery order, which is expected to be completed by August 26, 2025, is issued under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at $471.0 million and running through September 1,...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $1,024.90 by the Defense Logistics Agency's Medical Supply Chain on August 7, 2025, with an ultimate completion date of August 12, 2025. This fixed-price contract with economic price adjustment is a delivery order under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at $471,048,172.66 and running...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a delivery order valued at $6,808.01 from the Defense Logistics Agency's Medical Supply Chain on August 26, 2025, with completion targeted for August 29, 2025. This fixed-price contract with economic price adjustment represents a task order under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at $471,048,172.66 and running through...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a delivery order valued at $30,577.00 from the Defense Logistics Agency's Medical Supply Chain on August 26, 2025. This fixed-price contract with economic price adjustment provisions is set to conclude by September 10, 2025, and represents a task order under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at $471 million and...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a $133,490.93 fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on September 24, 2025, with completion expected by September 29, 2025. This delivery order, issued without set-aside designation, represents a task order under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at $471,048,172.66 and...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a delivery order valued at $1,980.00 from the Defense Logistics Agency's Medical Supply Chain on August 4, 2025, with an ultimate completion date of August 18, 2025. This fixed-price delivery order with economic price adjustment authority (Contract Number 4568979999) was awarded without a set-aside designation, reflecting Arthrex's strong competitive position in the federal orthopedic...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a $3,025.44 delivery order on August 1, 2025, with an ultimate completion date of August 6, 2025. This fixed-price delivery order with economic price adjustment was issued under the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal program supporting government healthcare systems. The contract carries no set-aside designation, reflecting Arthrex's competitive...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a $4,843.82 fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on February 6, 2025, with an ultimate completion date of February 11, 2025. The contract, awarded without set-aside restrictions, represents a task order under Arthrex's larger Indefinite Delivery Contract (IDC SPE2DE24D0020) with the Defense Logistics Agency, valued at $471,048,172.66 and...
- Arthrex Inc., a leading developer and manufacturer of minimally invasive orthopedic medical technologies, received a delivery order valued at $3,025.44 from the Defense Logistics Agency's Medical Supply Chain on September 16, 2025. This fixed-price delivery order with economic price adjustment is scheduled for completion by September 19, 2025, and will be performed at the company's headquarters in Naples, Florida. The award utilized no set-aside designation, reflecting Arthrex's strong...
- SPE2DE24DA011Indefinite Delivery Contract
- SPE2DE24DA011-SPE2D625F9D4UDelivery Order
Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a delivery order valued at $2,437.38 from the Defense Logistics Agency's Medical Supply Chain on May 20, 2025. This fixed-price delivery order with economic price adjustment is scheduled for completion by May 29, 2025, and represents work performed under Arthrex's existing Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at approximately $471 million through September 1, 2029. The contract was awarded without set-aside restrictions, reflecting Arthrex's strong competitive standing in the federal orthopedic medical device marketplace. This delivery order falls under Arthrex's comprehensive IDC vehicle, which enables Veterans Affairs medical centers and Department of Defense facilities nationwide to procure the company's full portfolio of orthopedic surgical solutions, including implants, arthroscopic instruments, joint replacement technologies, and specialized surgical instrument systems. Since the IDC's inception in June 2024, Arthrex has received over $550,000 in delivery orders, demonstrating consistent demand for its advanced medical technologies across multiple orthopedic specialties. The company's status as a parent vendor with no designated set-aside underscores its established capability to support government healthcare systems serving veterans and military personnel.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 5/20/25 |